Asthmatin 10mg (3 blisters x 10 tablets/box)

Indications

The prophylasis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. The relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older.

Contraindications

Known hypersensitivity to any of the active substance or excipients.

Compositon/Ingredients

Dosage and administration

Asthmatin should be taken once daily. Asthma or allergic rhinitis: adult and adolescents ≥ 15 years of age: 10 mg; pediatric patients 6 to 14 years of age: 5 mg, 2 to 5 years old: 4 mg. Pediatric patients 12 to 23 months of age with asthma, 6 to 23 months of age with perennial allergic rhinitis: 4 mg. Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis and in patients less than 12 months of age with asthma have not established.

Precaution

Bronchospasm in acute asthma attacks. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption Montelukast should not be abruptly substituted for inhaled or oral corticosteroids. Montelukast should not be used as monotherapy for the treatment and management of exercise-induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin/NSAIDs while taking montelukast. Montelukast should be used during pregnancy only if clearly essential. Caution should be exercised when montelukast is given to a nursing mother. Patients should be aware of how they react to drug before driving or operating machinery.

Storage

Store at temperature below 30°C, protect from light.